Sep 10, 2026 08:30AM
Sep 10, 2026 07:30AM
Aug 6, 2026 07:01AM
Aug 3, 2026 07:03AM
Aug 3, 2026 07:00AM
Jul 29, 2026 07:30AM
Jul 6, 2026 07:31AM TG Therapeutics starts Phase 2 trial of Briumvi for schizophrenia
Jul 6, 2026 07:30AM
Jun 24, 2026 08:30AM
Jun 9, 2026 07:30AM
Jun 9, 2026 07:30AM
Jun 3, 2026 07:30AM
Jun 3, 2026 07:30AM
Jun 2, 2026 07:30AM TG Therapeutics to Participate in the Goldman Sachs 47th Annual Healthcare Conference
Jun 1, 2026 07:30AM
Jun 1, 2026 07:30AM
May 28, 2026 07:30AM
May 27, 2026 07:31AM
May 27, 2026 07:30AM
May 26, 2026 07:30AM
May 26, 2026 07:30AM TG Therapeutics Announces Data Presentations for BRIUMVI® at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting
May 6, 2026 07:00AM
May 5, 2026 07:01AM
Apr 30, 2026 07:30AM
Apr 22, 2026 07:32AM
Apr 22, 2026 07:30AM
Apr 15, 2026 07:30AM
Apr 15, 2026 07:30AM TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 12, 2026 07:00AM
Mar 9, 2026 07:31AM
Mar 9, 2026 07:30AM
Mar 6, 2026 07:31AM
Mar 6, 2026 07:30AM TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting
Feb 26, 2026 07:00AM
Feb 23, 2026 07:30AM
Feb 17, 2026 07:30AM
Feb 8, 2026 04:17PM
Feb 6, 2026 07:30AM
Feb 6, 2026 07:30AM
Jan 27, 2026 07:32AM TG Therapeutics to present BRIUMVI data at multiple sclerosis conference
Jan 27, 2026 07:30AM
Jan 13, 2026 04:25PM
Jan 13, 2026 04:25PM
Jan 7, 2026 07:30AM
Nov 28, 2025 07:30AM
Nov 19, 2025 08:30AM
Nov 10, 2025 04:00PM TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
Nov 3, 2025 07:00AM

330,707 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All